For decades, constructive collaborations between investigators and industry have benefited patients and the public. Recently, high-profile lawsuits (1), public interest groups, and politicians (2) have raised concerns that financial and other interests may unduly influence professional judgment and threaten the integrity of scientific research. As a result of the attention regarding payments to physicians, a sense of urgency has arisen to better detect and deal with conflicts. Multiple efforts have emerged to mitigate the conflicts and promote objectivity in research. Individual states (3), professional organizations (4), and even industry (5) promote more rigorous reporting and restrictions. In addition to the Food and Drug Administration (FDA) regulations (6), the Public Health Service (PHS) National Institutes of Health (NIH) proposed new, more stringent guidelines in May 2010 aimed at preventing financial conflict of interests among researchers who receive federal research funding (7).